Outcome Assessment using SF-36 v2 in Stroke Patient Study

UMIN ID: C000000293

Registered date:31/05/2008

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Brain infarction
• Date of first enrollment: 2005/10/01
• Target sample size: 2400
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: To determine the SF-36 v2 score and to investigate the effect on QOL of vertigo, dizziness, presyncope, and light-headedness after chronic brain infarction

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1. Patients who cannot read, understand and fill in the questionnaire by themselves 2. Patients who idle their time away 3. Patients who are hospitalized 4. Patients who are undergoing treatment for dizziness, vertigo, presyncope, light-headedness which are likely due to chronic cerebral circulation impairment associated with sequelae of brain infarction 5. Patients whose dizziness, vertigo, presyncope, and light-headedness is definitely or likely caused by Meniere disease, vestibular neuronitis, benign paroxysmal positional vertigo, otitis media, or epilepsy 6. Patients whom the investigator judges are not suitable to participate in the study

Related Information

• Primary Sponsor: OASIS STUDY Research Group
• Source(s) of Monetary Support: Kyorin Pharmaceutical Co, Ltd